LABIANCA, ROBERTO FRANCESCO
LABIANCA, ROBERTO FRANCESCO
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial
2020 Barni, S; Rosati, G; Lonardi, S; Pella, N; Banzi, M; Zampino, M; Dotti, K; Rimassa, L; Marchetti, P; Maiello, E; Artioli, F; Ferrari, D; Labianca, R; Bidoli, P; Zaniboni, A; Sobrero, A; Iaffaioli, V; De Placido, S; Frassineti, G; Ciarlo, A; Buonadonna, A; Silvestris, N; Piazza, E; Pavesi, L; Moroni, M; Clerico, M; Aglietta, M; Giordani, P; Galli, F; Galli, F; Petrelli, F
Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma
2003 Manenti, L; Paganoni, P; Floriani, I; Landoni, F; Torri, V; Buda, A; Taraboletti, G; Labianca, R; Belotti, D; Giavazzi, R
| Titolo | Tipologia | Data di pubblicazione | Autori | File |
|---|---|---|---|---|
| Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial | 01 - Articolo su rivista | 2020 | Labianca R.Bidoli P. + | |
| Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma | 01 - Articolo su rivista | 2003 | Landoni F.Buda A.Labianca R. + |